By Eduard Kovacs on March 01, 2021
TripleBlind, a Kansas City, Missouri-based startup that provides data privacy solutions, on Monday announced raising $8.2 million in seed funding.
The oversubscribed funding round was led by Dolby Family Ventures, with participation from several companies and angel investors. Investors include Okta Ventures, NextGen Venture Partners, Operator Partners, Wavemaker Three-Sixty Health, AVG Basecamp Fund, Anorak Ventures, Quiet Capital, Clocktower Technology Ventures, Parity Responsible Technology Fund, Manresa Ventures, Accenture Ventures, Flyover Capital and KCRise Fund.
TripleBlind told SecurityWeek that it emerged from stealth mode in November 2020, when Accenture announced a strategic investment in the company.
Founded in 2019, TripleBlind has developed a de-identification and data privacy solution that enables organizations to share, use and monetize sensitive information including personal, financial and health data without the fear of vi
Carlsmed Raises $10M to Commercialize Breakthrough aprevo™ Devices Today, Carlsmed, Inc. announces the close of a $10M Series A financing to commercialize the
aprevo family of spine deformity correction devices. The San Diego-based medical device company is focused on improving outcomes for patients with adult spinal deformity. Carlsmed has pioneered a novel digital + surgical solution to create optimized surgical plans and personalized
aprevo implants to enable superior correction of the spinal deformity. This round of financing is led by U.S. Venture Partners (USVP) and includes participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. This round of financing comes at the perfect time to meet surgeon and patient demand for the newly launched Breakthrough
Carlsmed, Inc., a San Diego, CA-based medical device company, closed a $10M Series A financing round.
The round was led by U.S. Venture Partners with participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others.
The company intends to use the funds to commercialize its devices.
Led by Mike Cordonnier, CEO, Carlsmed is the maker of the
aprevo family of spine deformity correction devices. Its novel digital + surgical solution creates optimized surgical plans and personalized implants to enable superior correction of the spinal deformity.
In conjunction with the Series A closing, the company announced the appointment of three directors to the board, Jonathan Root, M.D., Phil Young, and Kevin Sidow.
FAIRFIELD-SUISUN, CALIFORNIA
San Diego’s Carlsmed corrals $10 million to bring personalized medicine to spine surgeries [The San Diego Union-Tribune]
San Diego’s Carlsmed, which received regulatory approval last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding.
The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S.
Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data and other information to design personalized implants for surgeries to straighten the spine, said Mike Cordonnier, chief executive and co-founder of Carlsmed.
Daily Business Report-Dec 17, 2020, San Diego Metro Magazine sandiegometro.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegometro.com Daily Mail and Mail on Sunday newspapers.